{"disease":{"id":"ffi","name":"ffi"},"drugs":{"marketed":[{"drug_id":"ciclosporin","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"Ciclosporin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":68,"revenue":"1866.0","mechanism":""},{"drug_id":"cyclosporine","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"cyclosporine","company_name":"Novartis AG (originally Sandoz)","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"Calcineurin inhibitor (immunosuppressant)","quality_score":67,"revenue":"1866.0","mechanism":"Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection."},{"drug_id":"fidaxomicin","indication_name":"Clostridium difficile infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dificid","generic_name":"FIDAXOMICIN","company_name":"Cubist Pharms Llc","drug_phase":"marketed","molecular_target":"","drug_class":"Macrolide Antibacterial [EPC]","quality_score":65,"revenue":"410.0","mechanism":"Dificid works by inhibiting protein synthesis in bacteria, preventing them from reproducing and causing infection."},{"drug_id":"ether","indication_name":"Relief of difficulty sleeping","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ETHER","company_name":"","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Primary or secondary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Acute adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"pancrelipase","indication_name":"Exocrine Pancreatic Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PANCRELIPASE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":36,"revenue":null,"mechanism":"Pancreatic enzyme products catalyze the breakdown of fats, proteins, and starches in the duodenum and proximal small intestine, mimicking natural pancreatic enzymes."},{"drug_id":"chlorella","indication_name":"Difficulty losing weight","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Chlorella","company_name":"Cardinal Tien Hospital","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"pancrelipase","indication_name":"Exocrine Pancreatic Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PANCRELIPASE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":36,"revenue":null,"mechanism":"Pancreatic enzyme products catalyze the breakdown of fats, proteins, and starches in the duodenum and proximal small intestine, mimicking natural pancreatic enzymes."},{"drug_id":"doxepin-hydrochloride","indication_name":"Insomnia with sleep maintenance difficulty","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DOXEPIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"H1 receptor","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Doxepin may help maintain sleep by blocking H1 receptors."},{"drug_id":"macrogol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miralax","generic_name":"Macrogol","company_name":"Braintree","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-succinate","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-succinate","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"distigmine","indication_name":"Difficulty passing urine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ubretid","generic_name":"DISTIGMINE","company_name":"Torii Pharmaceuticals","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"distigmine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"vancomycin","indication_name":"Clostridium difficile diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vancocin","generic_name":"vancomycin","company_name":"ANI Pharmaceuticals","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor, D-alanyl-D-alanine dipeptidase, UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone-acetate","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"lifitegrast","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xiidra","generic_name":"LIFITEGRAST","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Intercellular adhesion molecule 1","drug_class":"Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]","quality_score":48,"revenue":null,"mechanism":"Xiidra works by blocking the interaction between immune cells and the surface of the eye, reducing inflammation and promoting tear production."},{"drug_id":"polysorbate-80","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Polyethoxylated Sorbitan Monooleate","generic_name":"POLYSORBATE 80","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"fludrocortisone-acetate","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Florinef","generic_name":"FLUDROCORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"fludrocortisone","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"dhea","indication_name":"insufficiencies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hormone Harmony","generic_name":"DHEA","company_name":"Pro Weight Loss Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Gonadotropin [EPC]","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"dhea","indication_name":"hormone imbalances of insufficiencies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hormone Harmony","generic_name":"DHEA","company_name":"Pro Weight Loss Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Gonadotropin [EPC]","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"crospovidone","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Povidone","generic_name":"CROSPOVIDONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antiseptic [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"tetracosactide","indication_name":"Diagnostic Test for Secondary Adrenocortical Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortrosyn","generic_name":"tetracosactide","company_name":"Amphastar Pharms Inc","drug_phase":"marketed","molecular_target":"Melanocortin receptor 4","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fludrocortisone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Florinef","generic_name":"fludrocortisone","company_name":"Generic","drug_phase":"marketed","molecular_target":"Annexin A1, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Mineralocorticoid","quality_score":43,"revenue":null,"mechanism":""},{"drug_id":"endometrin","indication_name":"Corpus Luteum Insufficiency Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endometrin","generic_name":"progesterone","company_name":"Ferring","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"Progesterone [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"ciclosporine","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ciclosporine","company_name":"Hospices Civils de Lyon","drug_phase":"phase_3","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"prednison","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"methylprednisolone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"monoxerutin","indication_name":"Peripheral venous insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MONOXERUTIN","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Monoxerutin works by improving blood vessel function and reducing inflammation."},{"drug_id":"hydrocortisone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"lutein","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xanthophyll","generic_name":"LUTEIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cosyntropin","indication_name":"Screening for adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"COSYNTROPIN","company_name":"","drug_phase":"marketed","molecular_target":"MC2 receptor","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"bezlotoxumab","indication_name":"Clostridium difficile infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zinplava","generic_name":"BEZLOTOXUMAB","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Zinplava works by binding to and neutralizing toxins produced by Clostridium difficile bacteria."},{"drug_id":"polyvinyl-alcohol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vinyl Alcohol Polymer","generic_name":"POLYVINYL ALCOHOL","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Polyvinyl alcohol works by forming a protective barrier on the surface of the eye to help repair and maintain the tear film."},{"drug_id":"metyrapone","indication_name":"Diagnostic Test for Secondary Adrenocortical Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metopirone","generic_name":"METYRAPONE","company_name":"Esteve","drug_phase":"marketed","molecular_target":"Cytochrome P450 11B1, mitochondrial","drug_class":"Adrenal Steroid Synthesis Inhibitor [EPC]","quality_score":60,"revenue":null,"mechanism":"Metopirone works by inhibiting the enzyme responsible for converting a precursor into cortisol, effectively reducing cortisol production."},{"drug_id":"terbutaline","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Primary or secondary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"betamethasone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"diquafosol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Up4U","generic_name":"DIQUAFOSOL","company_name":"Santen Pharmaceutical","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 2","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"neoral","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neoral","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cyclosporin","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cyclosporin","company_name":"Karolinska University Hospital","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xiidra","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xiidra","company_name":"Qilu Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Integrin alpha-L/beta-2, Intercellular adhesion molecule 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"progesteron","indication_name":"Corpus Luteum Insufficiency Syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Progesteron","company_name":"Minia University","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Severe adrenal insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"betamethasone","indication_name":"Primary adrenocortical insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"fludrocortisone","indication_name":"Primary and Secondary Adrenocortical Insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Florinef","generic_name":"fludrocortisone","company_name":"Generic","drug_phase":"marketed","molecular_target":"Annexin A1, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Mineralocorticoid","quality_score":43,"revenue":null,"mechanism":""},{"drug_id":"tetracosactide","indication_name":"Adrenocortical insufficiency screening","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortrosyn","generic_name":"tetracosactide","company_name":"Amphastar Pharms Inc","drug_phase":"marketed","molecular_target":"Melanocortin receptor 4","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"chlorthalidone","indication_name":"Safety and efficacy of chlorthalidone in type 1 diabetes","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlorthalidone","indication_name":"Efficacy and safety of olmesartan associated with chlorthalidone in essential arterial hypertension","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":64,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT05455528","title":"Preoperative Renal Insufficiency Predicts Postoperative Adverse Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":2421286,"lead_sponsor_name":"Taipei Medical University Hospital","has_results":false},{"nct_id":"NCT04480996","title":"Evaluation of Reporting of Road Traffic Accidents With Drugs Responsible for Cognitive Side Effects (ERoADS)","phase":"","overall_status":"UNKNOWN","enrollment_count":500000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT04541498","title":"Impact of Air Pollution and Climate Changes on the Epidemiology of Cardiovascular Disease","phase":"","overall_status":"COMPLETED","enrollment_count":150000,"lead_sponsor_name":"Medical University of Bialystok","has_results":false},{"nct_id":"NCT04014608","title":"Protocol for Admission Toxigenic C. Difficile Surveillance","phase":"","overall_status":"COMPLETED","enrollment_count":148549,"lead_sponsor_name":"Endeavor Health","has_results":false},{"nct_id":"NCT03575247","title":"The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":111804,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT07065812","title":"Team Familiarity and Perioperative Outcomes in Non-Cardiac Surgery","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT03518918","title":"Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women","phase":"","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04974138","title":"China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":32000,"lead_sponsor_name":"Shenzhen Ausa Pharmed Co.,Ltd","has_results":false},{"nct_id":"NCT07282665","title":"A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":32000,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT01767883","title":"Improving Evidence-Based Primary Care for Chronic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":27000,"lead_sponsor_name":"American Academy of Family Physicians","has_results":false},{"nct_id":"NCT04054440","title":"Outpatient Office Based Endovascular Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":26000,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT03349268","title":"Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":25732,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT00960128","title":"Observational Prospective Study on Patients Treated With Norditropin®","phase":"","overall_status":"COMPLETED","enrollment_count":21249,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06955195","title":"Youth-for-Youth Mental Wellness Care and Action","phase":"NA","overall_status":"RECRUITING","enrollment_count":18000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03090191","title":"Clostridium Difficile Vaccine Efficacy Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":17535,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04458220","title":"Research on Early Warning and Solution System of Difficult Airway in Perioperative Period Based on Artificial Intelligence","phase":"","overall_status":"UNKNOWN","enrollment_count":16000,"lead_sponsor_name":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","has_results":false},{"nct_id":"NCT02769975","title":"Evaluation of Children With Endocrine and Metabolic-Related Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT02111564","title":"A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12024,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05932576","title":"A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT04993781","title":"Electronic Strategies for Tailored Exercise to Prevent FallS","phase":"NA","overall_status":"COMPLETED","enrollment_count":11945,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03826264","title":"Transpacific TAVR Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Duk-Woo Park, MD","has_results":false},{"nct_id":"NCT07484243","title":"Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Yuanyuan Zhang","has_results":false},{"nct_id":"NCT05884645","title":"The DAnish VIdeo IntubaTION (DA-VITION) Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Lise Aunsholt","has_results":false},{"nct_id":"NCT01887912","title":"Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":9302,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07103629","title":"Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap","phase":"","overall_status":"COMPLETED","enrollment_count":8428,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06339606","title":"Pregnancy Repository","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05440851","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","phase":"NA","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT03848689","title":"FQ Restriction for the Prevention of CDI","phase":"","overall_status":"COMPLETED","enrollment_count":5871,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT05630326","title":"Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants","phase":"","overall_status":"COMPLETED","enrollment_count":5600,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT07495436","title":"Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5562,"lead_sponsor_name":"Hospital Clinico Universitario de Santiago","has_results":false},{"nct_id":"NCT05722769","title":"CSTOP Now! Child Sex Trafficking Stops With You","phase":"NA","overall_status":"RECRUITING","enrollment_count":5408,"lead_sponsor_name":"Ann Coker","has_results":false},{"nct_id":"NCT03041987","title":"Chinese Cohort Study of Chronic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03882580","title":"Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT03899298","title":"Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"R3 Stem Cell","has_results":false},{"nct_id":"NCT03921242","title":"Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":4888,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT03223415","title":"Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":4138,"lead_sponsor_name":"Yves Longtin","has_results":false},{"nct_id":"NCT07261826","title":"Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Chen QiYi","has_results":false},{"nct_id":"NCT05207254","title":"Research on the Application of Artificial Intelligence Ultrasonic Recognition Technology in Difficult Airway Assessment","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","has_results":false},{"nct_id":"NCT05993026","title":"A School-based Intervention to Promote Mental Health and Self-efficacy Among Students in 7th to 10th Grade","phase":"NA","overall_status":"COMPLETED","enrollment_count":3966,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT03857464","title":"C Difficile Near-patient Diagnostics","phase":"NA","overall_status":"COMPLETED","enrollment_count":3816,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04509479","title":"National Tunisian Registry of Valvulopathies (NATURE-VALVE)","phase":"","overall_status":"COMPLETED","enrollment_count":3637,"lead_sponsor_name":"Dacima Consulting","has_results":false},{"nct_id":"NCT05776550","title":"Safety and Efficacy of Distal Radial Approach (SAFE-BOX)","phase":"","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT01661387","title":"A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)","phase":"","overall_status":"TERMINATED","enrollment_count":3258,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT02788253","title":"Mallampati Classification vs Best Visible Mallampati for Prediction of Difficult Tracheal Intubation","phase":"","overall_status":"COMPLETED","enrollment_count":3244,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT03503474","title":"COMBACTE-CDI Understanding the Burden of C. Difficile Infection","phase":"","overall_status":"COMPLETED","enrollment_count":3240,"lead_sponsor_name":"University of Leeds","has_results":true},{"nct_id":"NCT06587529","title":"Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":3218,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT06232837","title":"Macintosh Blade Size for Endotracheal Intubation in Operative Rooms","phase":"","overall_status":"COMPLETED","enrollment_count":3058,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT06364280","title":"Pediatric Prehospital Airway Resuscitation Trial","phase":"NA","overall_status":"SUSPENDED","enrollment_count":3000,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT03013166","title":"THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT06693440","title":"The Immune Assessment of PD-1 Antibody Therapy in Tumor","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Quanli Gao","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}